Scrotal biopsy

Biopsy

Report in 240Hrs

At Home

No Fasting Required

Details

Tissue biopsy of scrotum.

₹296₹423

30% OFF

Scrotal Biopsy - Comprehensive Medical Test Information Guide

Why is it done?
- Test Purpose: A scrotal biopsy involves the removal of a small tissue sample from the scrotum or testicles for microscopic examination. This test helps identify the cause of testicular or scrotal pathology and assists in diagnosing various medical conditions affecting reproductive health.
- Primary Indications: Evaluation of azoospermia (absence of sperm); Assessment of obstructive vs. non-obstructive azoospermia; Investigation of testicular masses or lumps; Evaluation of infertility; Suspected testicular cancer or malignancy; Assessment of testicular inflammation (orchitis); Evaluation of chronic testicular pain; Assessment of testicular atrophy; Diagnosis of testicular torsion complications
- Typical Timing: Performed as an outpatient procedure; May be done acutely if testicular malignancy is suspected; Can be scheduled electively for infertility evaluation; Often performed after imaging studies (ultrasound) have identified suspicious lesions
Normal Range
- Normal Histology Findings: Normal testicular tissue shows intact seminiferous tubules; Presence of spermatogenic cells at all stages of development; Normal Sertoli cells and Leydig cells; No fibrosis or calcifications; No inflammatory infiltrates; Normal blood vessel architecture
- Scrotal Skin Normal Findings: Normal epithelium without dysplasia or malignancy; No evidence of infection or inflammation; Normal hair follicles and sebaceous glands; Absence of pathogenic organisms
- Interpretation Categories: Negative/Benign: No malignancy, infection, or significant pathology; Positive: Presence of abnormal cells or pathological findings; Borderline: Suspicious findings requiring additional evaluation or follow-up; Report includes detailed histopathologic description and clinical correlation recommendations
Interpretation
- Benign Findings: Normal spermatogenesis indicates adequate testicular function; Maturation arrest suggests interruption in sperm development requiring investigation; Sertoli cell-only syndrome indicates absent spermatogenesis; Hypospermatogenesis suggests reduced sperm production
- Malignant Findings: Germ cell tumors (seminomas, non-seminomas) indicate cancer requiring oncologic management; Leydig cell tumors may produce hormonal effects; Squamous cell carcinoma or melanoma of scrotal skin indicate cutaneous malignancy; Lymphomas require staging and systemic therapy
- Inflammatory Findings: Granulomatous inflammation suggests granulomatosis or infection; Acute inflammation indicates recent infection or trauma; Chronic inflammation may indicate autoimmune disease; Infectious organisms (bacteria, fungi, organisms) guide antimicrobial therapy
- Structural Abnormalities: Fibrosis suggests prior trauma, infection, or torsion; Calcifications may indicate prior infarction or torsion; Tubular dilatation suggests obstruction; Vascular abnormalities may indicate prior thrombosis
- Factors Affecting Results: Patient age (changes with aging); Hormonal status (testosterone, FSH, LH levels); Prior chemotherapy or radiation; Varicocele presence; Cryptorchidism history; Reproductive history; Medications (corticosteroids, cytotoxic agents)
Associated Organs
- Primary Organ Systems: Male reproductive system (testes, scrotum, epididymis); Endocrine system (hormone production); Lymphatic system (metastatic potential)
- Associated Medical Conditions: Testicular cancer (seminomas, non-seminomas, Leydig cell tumors); Male infertility syndromes; Azoospermia (obstructive and non-obstructive); Orchitis and epididymitis; Testicular torsion complications; Varicocele-related changes; Cryptorchidism; Testicular trauma; Genital tuberculosis; Syphilis; Leprosy
- Diagnostic Significance: Definitive diagnosis of testicular malignancy; Determination of obstructive versus non-obstructive azoospermia; Identification of specific spermatogenic defects; Detection of infections and inflammatory conditions; Assessment of infertility etiology; Tissue analysis for genetic abnormalities (Klinefelter syndrome patterns)
- Potential Complications: Metastatic disease if malignancy present; Hormonal insufficiency if extensive testicular damage; Fertility compromise from testicular injury; Infection risk; Hematocele formation; Testicular atrophy in advanced disease; Systemic spread of malignancy requiring chemotherapy or radiation
Follow-up Tests
- If Malignancy Detected: CT imaging of chest, abdomen, and pelvis; Tumor markers (AFP, beta-hCG, LDH); Radical inguinal orchiectomy; Retroperitoneal lymph node dissection evaluation; PET scan for metastatic disease staging; Bone scan if clinically indicated
- If Azoospermia Confirmed: Hormone panel (FSH, LH, testosterone); Karyotype analysis; Y chromosome microdeletion testing; Genetic counseling referral; Assisted reproductive technology consultation; Consider testicular sperm extraction (TESE) for obstructive cases
- If Infection Identified: Culture and sensitivity testing; Antimicrobial susceptibility testing; Specific organism identification; Infectious disease consultation if indicated; Follow-up imaging to monitor resolution
- If Inflammation Present: Rheumatologic workup if autoimmune suspected; Anti-inflammatory markers (ESR, CRP); Immunologic testing if granulomatosis considered; Follow-up ultrasound; Clinical monitoring
- General Monitoring: Periodic clinical examination of scrotum; Repeat ultrasound if clinically indicated; Semen analysis follow-up for fertility assessment; Hormone level monitoring; Imaging surveillance if malignancy history; Annual examination in cancer survivors
Fasting Required?
- Fasting Requirement: No - Fasting is not required for scrotal biopsy
- Pre-procedure Preparation: Avoid extensive exercise 24 hours before procedure; Avoid sexual activity 24-48 hours before biopsy; Bathe or shower before procedure; Wear clean, loose-fitting clothing; Remove jewelry from scrotal area if applicable
- Medication Instructions: Inform provider of all current medications; Discontinue anticoagulants (warfarin, dabigatran) 3-5 days before procedure if possible; Stop antiplatelet agents (aspirin, clopidogrel) 5-7 days prior if medically safe; Continue essential medications as directed; Avoid NSAIDs 3-5 days before biopsy to reduce bleeding risk; Arrange anesthesia consultation for local or general anesthesia clearance
- Anesthesia Considerations: Procedure typically performed under local anesthesia with lidocaine; General anesthesia may be used in anxious patients or difficult cases; NPO (nothing by mouth) requirements depend on anesthesia type used; Discuss anesthesia options with urologist beforehand
- Post-procedure Care: Resume normal diet immediately after local anesthesia; Avoid strenuous activity for 3-5 days; Wear supportive undergarments for comfort; Apply ice packs for 15-20 minutes as needed; Take prescribed pain medication if necessary; Avoid sexual activity for 1-2 weeks; Keep biopsy site clean and dry

How our test process works!